Zobrazeno 1 - 10
of 134
pro vyhledávání: '"A. M. Ehrly"'
Autor:
Albrecht M. Ehrly
Publikováno v:
Clinical Hemorheology and Microcirculation. 10:573-576
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 124:1485-1488
HISTORY AND CLINICAL FINDINGS A 39 year-old man presented with dyspnoea and calf pain. Aside from two long-distance flights there were no triggering events for deep vein thrombosis (DVT). 6 years before the patient had had a spontaneous DVT. Family h
Autor:
P. Oertel, A M Ehrly, Edelgard Lindhoff-Last, Gerlinde Mosch, Frank Gerdsen, L. Junker, J. Ziems, D. Meißner
Publikováno v:
LaboratoriumsMedizin. 21:489-499
Autor:
A. M. Ehrly
Publikováno v:
Drugs. 39:155-159
The most important haemorheologically active drugs and their role in therapy are briefly discussed (haemodilution, fibrinolytic drugs, drugs that improve red cell deformability)
Autor:
A M, Ehrly, R M, Bauersachs
Publikováno v:
Clinical hemorheology and microcirculation. 20(1)
Publikováno v:
Zentralblatt fur Gynakologie. 122(1)
Venous thromboembolism (VTE) remains the leading cause of maternal death. Today, various risk factors and conditions are known to increase the risk for VTE associated with pregnancy. Having identified the individual risk of a pregnant women, appropri
Autor:
Judith Plagemann, P Eichler, R. M. Bauersachs, Martina Stein, Albert M. Ehrly, Frank Gerdsen, Richard Wagner, Edelgard Lindhoff-Last
Publikováno v:
Thrombosis research. 97(6)
The heparin-platelet factor 4-antibody assay, polyanion-platelet factor 4-antibody assay and heparin-induced platelet activation test are used for laboratory diagnosis of the immune form of heparin-induced thrombocytopenia. Fifty consecutive patients
Publikováno v:
Clinical hemorheology and microcirculation. 21(1)
The objective of the study was to identify the relative importance of erythrocyte flow resistance and aggregation in acute and chronic coronary syndromes. 117 subjects in five groups were studied: (1) 34 patients shortly after acute myocardial infarc